University of British Columbia

Vancouver, British Columbia, Canada

22 recruiting

Showing 120 of 52 trials

Recruiting
Phase 2

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)66 enrolled10 locationsNCT07142252
Recruiting
Phase 3

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Metabolic Dysfunction-Associated Steatohepatitis
Boehringer Ingelheim1,590 enrolled447 locationsNCT06632457
Recruiting
Phase 4

Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)

Major Depressive Disorder
Nova Scotia Health Authority400 enrolled10 locationsNCT05017311
Recruiting
Phase 3

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

Metabolic dysfunction-associated steatohepatitis (MASH)Liver Fibrosis
Boehringer Ingelheim1,800 enrolled526 locationsNCT06632444
Recruiting
Phase 3

Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.

Prostate Cancer Screening
University of Alberta1,284 enrolled9 locationsNCT06626022
Recruiting
Not Applicable

MAPT Protocol: Fixation Versus Arthroplasty Surgical Treatments for Early Recovery After HIP Fracture (FASTER-HIP)

Femoral Neck Fractures
University of Southern California600 enrolled13 locationsNCT07244211
Recruiting
Not Applicable

Evaluating XPERIENCE™ Advanced Surgical Irrigation

Knee Osteoarthritiship osteoarthritisHip Arthritis+1 more
Ottawa Hospital Research Institute7,600 enrolled8 locationsNCT05543941
Recruiting

Predictors of Relapse in Major Depressive Disorder (PERFORM-D)

Major Depressive Disorder (MDD)
Abraham Nunes252 enrolled8 locationsNCT06746155
Recruiting
Phase 2

Study of COYA 302 for the Treatment of ALS

Amyotrophic Lateral Sclerosis(ALS)
Coya Therapeutics120 enrolled25 locationsNCT07161999
Recruiting
Phase 3

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

CardiomyopathiesAmyloidosisHeart Diseases+3 more
Eidos Therapeutics, a BridgeBio company587 enrolled101 locationsNCT06563895
Recruiting
Not Applicable

Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

Colorectal, CancerColorectal NeoplasmsColorectal Polyp+2 more
Dartmouth-Hitchcock Medical Center8,946 enrolled22 locationsNCT05612347
Recruiting
Phase 1Phase 2

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

Myelofibrosis
Sumitomo Pharma America, Inc.240 enrolled84 locationsNCT04176198
Recruiting
Phase 3

Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy

Open tíbia Fracture
University of Maryland, Baltimore312 enrolled34 locationsNCT05615844
Recruiting

International Severe Asthma Registry: Canadian Cohort

Severe Asthma
University of British Columbia714 enrolled12 locationsNCT04045587
Recruiting
Not Applicable

Nanochon Chondrograft First in Human (FIH) Early Feasibility Study (EFS) - Canada

Knee Cartilage Lesions
Nanochon, Inc.10 enrolled2 locationsNCT07249489
Recruiting
Not Applicable

Exercise in Perimenopause to Improve Cognitive Health

Subjective Cognitive ComplaintsPerimenopause
University of British Columbia50 enrolled1 locationNCT07272174
Recruiting

Selective CT for Anticoagulated Head Injured Patients

Traumatic Brain InjuryHead InjuryIntracranial Hemorrhage, Traumatic+1 more
Dr. Kerstin de Wit4,000 enrolled7 locationsNCT05364749
Recruiting
Not Applicable

Micro-UltraSound In Cancer - Active Surveillance

Prostate Cancer
University of Alberta210 enrolled5 locationsNCT05558241
Recruiting
Phase 2

Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy

Arrhythmogenic CardiomyopathyArrhythmogenic Right Ventricular Cardiomyopathy
Hamilton Health Sciences Corporation120 enrolled17 locationsNCT06174220
Recruiting

VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study

Crohn's Disease
Alimentiv Inc.300 enrolled25 locationsNCT06249555